"It's critical to understand further the triggers that contribute to the development of Parkinson's disease and how inflammation may interact with proteins found in the disease. With this information, we could potentially provide new approaches for treatments by altering or interfering with these inflammatory pathways that may act as a trigger for the disease," says David Beckham, MD, associate professor of infectious diseases at the University of Colorado School of Medicine.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045